Skip to content

Piperaquine

ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

Also known as: piperaquine phosphate, piperaquine tetraphosphate, piperaquinoline

EMA approvedATC P01BF05ATC P01BF07ATC P01BX02

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Piperaquine is a drug catalogued in DrugCentral. It was first approved by the EMA in 2011. Recorded indications include Malaria.

  • Indications: Malaria.
  • ATC code: P01BF05 (Artemisinin and derivatives, combinations).
  • Molecular formula: C29H32Cl2N6; molecular weight 535.52 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Malaria

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
2011-10-27EMA—Sigma-Tau Industrie Farmaceutiche Riunite S.p.A

ATC classification

ATC codeTherapeutic hierarchy
P01BF05ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Artemisinin and derivatives, combinations
P01BF07ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Artemisinin and derivatives, combinations
P01BX02ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Other antimalarials

Chemical structure

Molecular formulaC29H32Cl2N6
Molecular weight535.52 g/mol
CAS number4085-31-8
InChIKeyUCRHFBCYFMIWHC-UHFFFAOYSA-N
PubChem CID122262
ClC1=CC=C2C(=C1)N=CC=C2N1CCN(CCCN2CCN(CC2)C2=CC=NC3=CC(Cl)=CC=C23)CC1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Piperaquine used for?

DrugCentral lists the following indications for Piperaquine: Malaria.

When was Piperaquine first approved?

Piperaquine was first approved by the EMA in 2011.

What is the chemical formula of Piperaquine?

Piperaquine has the molecular formula C29H32Cl2N6 and a molecular weight of 535.52 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval2011-10-27
AgencyEMA
Targets0
Indications1
FormulaC29H32Cl2N6
DrugCentral ID4193
Interactive profile